Weiss Multi-Strategy Advisers’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,000	Closed	-$158K	–	572
2015 Q2	$158K	Buy	+10,000	New	+$121K	0.01%	419
2015 Q1	–	Sell	-20,000	Closed	-$210K	–	592
2014 Q4	$210K	Hold	20,000	–	–	0.01%	378
2014 Q3	$192K	Buy	20,000 +1,100	+6%	+$11.2K	﹤0.01%	495
2014 Q2	$218K	Buy	18,900 +3,900	+26%	+$35.5K	﹤0.01%	687
2014 Q1	$150K	Buy	+15,000	New	+$217K	﹤0.01%	930

Other funds holding RPTP

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TCP

Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Weiss Multi-Strategy Advisers's RPTP Position: Q2 2014 in Review

Weiss Multi-Strategy Advisers sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2014, closing a stake of 22,000 shares — an estimated $200K sold.

Weiss Multi-Strategy Advisers first reported a position in RPTP in Q4 2013 and held it in 2 quarters. The position peaked at $220K in Q1 2014. 74 funds tracked by Wall St. Rank hold RPTP as of Q2 2014.

Weiss Multi-Strategy Advisers reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2014 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 22,000 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2014, an estimated $200K.
Weiss Multi-Strategy Advisers first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2013 and held it in 2 quarters.
Weiss Multi-Strategy Advisers's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $220K in Q1 2014.
74 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2014, filed 14 Aug 2014.